Are you working on the new coronavirus disease (COVID-19)? Caduceus is offering the perfect method for you!
Derived from the Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1 (GenBank ID: MN908947.3), the new Coronavirus 2019-nCoV Proteome Microarray gives researchers access to serologically screen 4,883 individual peptides spanning the entire viral proteome.
The entire Coronavirus 2019-nCoV viral proteome is translated into overlapping peptides and printed onto glass slides. Patient sera is incubated on the chip and antibodies present in the sample bind to epitopes recognized within individual peptides. The resulting response profile may be compared across different samples to monitor B-cell responses over time, or to determine immunodominant epitopes that may be further validated as potential disease-specific biomarkers for IVD development.
High resolution epitope analysis of anti-2019-nCoV antibodies
Identification of anti-2019-nCoV epitope biomarkers
Development of IgG or IgM-based IVD tests for coronavirus diagnosis
Identification of neutralizing anti-2019-nCoV antibodies
Development of coronavirus vaccines
Development of anti-2019-nCoV antibodies for passive immunization
Discovery of prognostic epitopes for disease progression
Case contract tracing in epidemiology, identification of asymptomatic individuals
Coronavirus 2019-nCoV (Acute Respiratory Distress Syndrome)
Whole proteome of Wuhan seafood market pneumonia virus isolate Wuhan-Hu-1 (GenBank ID: MN908947.3) translated into 4,883 individual peptides